Last reviewed · How we verify
Placebo A (After CP)
Placebo A (After CP) is a Small molecule drug developed by Janssen Pharmaceutical K.K.. It is currently in Phase 3 development.
Placebo A is an inert control substance with no active pharmacological mechanism.
At a glance
| Generic name | Placebo A (After CP) |
|---|---|
| Sponsor | Janssen Pharmaceutical K.K. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, this agent contains no active pharmaceutical ingredient and produces no direct molecular or biological effect. It is used as a control comparator in clinical trials to assess the efficacy of active treatments by isolating the true drug effect from placebo response and natural disease progression.
Approved indications
Common side effects
Key clinical trials
- Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (PHASE3)
- Effectiveness of NMES in Swallowing Rehabilitation in Children With CP (NA)
- Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients (NA)
- Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations (NA)
- Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer (PHASE3)
- Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPS (PHASE4)
- Effects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DM (PHASE4)
- Study to Evaluate Efficacy of OLX10010 in Reducing Recurrence of Hypertrophic Scarring After Scar Revision Surgery (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo A (After CP) CI brief — competitive landscape report
- Placebo A (After CP) updates RSS · CI watch RSS
- Janssen Pharmaceutical K.K. portfolio CI
Frequently asked questions about Placebo A (After CP)
What is Placebo A (After CP)?
How does Placebo A (After CP) work?
Who makes Placebo A (After CP)?
What development phase is Placebo A (After CP) in?
Related
- Manufacturer: Janssen Pharmaceutical K.K. — full pipeline
- Compare: Placebo A (After CP) vs similar drugs
- Pricing: Placebo A (After CP) cost, discount & access